During a recent Senate HELP Committee hearing, expert witnesses argued that a lack of transparency, vertical integration, and misaligned incentives are the true drivers of the healthcare affordability ...
Three expert witnesses at a recent Senate HELP Committee hearing outlined weaknesses and misaligned incentives driving growth in the 340B drug pricing program. The 340B Drug Pricing Program has grown ...
We will not keep your email address; we ask for it so your friend knows the email isn't spam.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results